drugset / Trial / NCT06372522

Oxytocin in Multiparous Women

NCT06372522 ↗

Not yet recruiting 166 enrolled Rambam Health Care Campus
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized controlled trial investigating whether continuous oxytocin infusion in multiparous women shortens time to delivery, without altering maternal or neonatal outcomes, in augmented deliveries, compared to intermittent infusion.

Timeline

Start
2024-04
Primary completion
2026-04
Completion
2027-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 0.02 iu Intravenous

Indications